Total Funding
81
15
Total FundingDebt Financing raised
Growth Score
-4 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1213620
Melior Pharmaceuticals is a clinical stage pharmaceutical company developing treatment for metabolic disease and skin disorders.
- Andrew G. Reaume: President and CEO, Co-Founder
About the Company
Many blockbuster drugs were only serendipitously discovered to be efficacious in the indications for which they were ultimately marketed. For example, Viagra® ($2 billion annual sales), Gemzar® ($1.2 billion annual sales), Evista® ($1.0 billion annual sales) and Propecia® are all examples of drugs that were originally developed for use in one
indication but, by chance, were discovered to be effective for a very different one.
